Vita Therapeutics receives a $300K commercialization grant from Maryland Stem Cell Research Foundation (MSCRF) to advance VTA-110 for treatment of Limb-Girdle Muscular...

8
min read
June 5, 2020

test

Media Contact
Douglas Falk, MS
Chief Executive Officer & Co-Founder
VITA Therapeutics
info@vita-therapeutics.com
Investor Relations Contact
Douglas Falk, MS
Chief Executive Officer & Co-Founder
VITA Therapeutics
info@vita-therapeutics.com
Investor Relations Contact
Douglas Falk, MS
Chief Executive Officer & Co-Founder
VITA Therapeutics
info@vita-therapeutics.com

Other news

Vita Therapeutics strengthens leadership team with four key additions.
March 22, 2022
5
min read
Vita Therapeutics receives Orphan Drug Designation from FDA for new novel treatment.
July 23, 2020
10
min read
Vita Therapeutics is included in Governor Hogan’s announcement of “Maryland’s Future 20” - a list of the state’s most innovative companies exhibiting great potential for success.
November 17, 2020
10
min read